132 related articles for article (PubMed ID: 2745420)
1. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha 1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis.
Marini JC; Grange DK; Gottesman GS; Lewis MB; Koeplin DA
J Biol Chem; 1989 Jul; 264(20):11893-900. PubMed ID: 2745420
[TBL] [Abstract][Full Text] [Related]
2. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
[TBL] [Abstract][Full Text] [Related]
3. Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology.
Marini JC; Lewis MB; Wang Q; Chen KJ; Orrison BM
J Biol Chem; 1993 Feb; 268(4):2667-73. PubMed ID: 8094076
[TBL] [Abstract][Full Text] [Related]
4. Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.
Grange DK; Gottesman GS; Lewis MB; Marini JC
Nucleic Acids Res; 1990 Jul; 18(14):4227-36. PubMed ID: 1696002
[TBL] [Abstract][Full Text] [Related]
5. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
6. Sequence of normal canine COL1A1 cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta.
Campbell BG; Wootton JA; MacLeod JN; Minor RR
Arch Biochem Biophys; 2000 Dec; 384(1):37-46. PubMed ID: 11147834
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
Bateman JF; Hannagan M; Chan D; Cole WG
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
[TBL] [Abstract][Full Text] [Related]
8. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
Cabral WA; Chernoff EJ; Marini JC
Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
[TBL] [Abstract][Full Text] [Related]
9. A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.
Bonaventure J; Cohen-Solal L; Lasselin C; Maroteaux P
Hum Genet; 1992 Aug; 89(6):640-6. PubMed ID: 1511982
[TBL] [Abstract][Full Text] [Related]
10. Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.
Cohn DH; Apone S; Eyre DR; Starman BJ; Andreassen P; Charbonneau H; Nicholls AC; Pope FM; Byers PH
J Biol Chem; 1988 Oct; 263(29):14605-7. PubMed ID: 3170557
[TBL] [Abstract][Full Text] [Related]
11. Two additional cases of osteogenesis imperfecta with substitutions for glycine in the alpha 2(I) collagen chain. A regional model relating mutation location with phenotype.
Wang Q; Orrison BM; Marini JC
J Biol Chem; 1993 Nov; 268(33):25162-7. PubMed ID: 7693712
[TBL] [Abstract][Full Text] [Related]
12. A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis imperfecta.
Hawkins JR; Superti-Furga A; Steinmann B; Dalgleish R
J Biol Chem; 1991 Nov; 266(33):22370-4. PubMed ID: 1939261
[TBL] [Abstract][Full Text] [Related]
13. A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV proband.
Filie JD; Orrison BM; Wang Q; Lewis MB; Marini JC
Hum Mutat; 1993; 2(5):380-8. PubMed ID: 8257992
[TBL] [Abstract][Full Text] [Related]
14. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
[TBL] [Abstract][Full Text] [Related]
15. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.
Shapiro JR; Stover ML; Burn VE; McKinstry MB; Burshell AL; Chipman SD; Rowe DW
J Clin Invest; 1992 Feb; 89(2):567-73. PubMed ID: 1737847
[TBL] [Abstract][Full Text] [Related]
16. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta.
Forlino A; Keene DR; Schmidt K; Marini JC
Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651
[TBL] [Abstract][Full Text] [Related]
17. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta.
Bateman JF; Lamande SR; Dahl HH; Chan D; Mascara T; Cole WG
J Biol Chem; 1989 Jul; 264(19):10960-4. PubMed ID: 2500431
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
19. Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA.
Bateman JF; Lamande SR; Dahl HH; Chan D; Cole WG
J Biol Chem; 1988 Aug; 263(24):11627-30. PubMed ID: 3403550
[TBL] [Abstract][Full Text] [Related]
20. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
Willing MC; Cohn DH; Byers PH
J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
